- Home
- Clinical Trials
Panic Disorder Study Sydney DH PD
Panic Disorder Study
Darlinghurst Sydney
Do you have panic disorder? Do you experience repeated, unpredictable panic attacks without the presence of a known fear or stressor? Join our clinical trial of a new treatment that looks to normalise the stress response for people with panic disorder.
Register now and find out if this study is right for you.
Description
What to expect
Study details
Ages
18 - 65 years old
Duration
The study has a duration of approximately 15-weeks and involves 6 visits to the clinic and 9 video calls with research staff.
Compensation
Eligible participants will be reimbursed for travel-related costs
Eligibility Criteria
You may be eligible to participate if you:
• Are 18-65 years old with panic disorder.
• Have had a minimum of one full, unexpected panic attack in the week prior to screening for the study.
• Are medically stable on any current medication for at least 3 months.
Please note it is important that study participants remain on any of their current psychiatric medications through the length of the study.
Other inclusion and exclusion criteria apply.
Locations
Description
Panic Disorder is an anxiety disorder characterized by repeated, unpredictable, panic attacks which are experienced without the presence of a known fear of stressor.
Current medicinal treatment options include serotonin and norepinephrine reuptake inhibitors (SSRI/SNRIs) and benzodiazepines (BDZs). However new treatments that safely improve the symptoms of a panic disorder without the adverse effects or serious toxicities of these current medications, are desperately needed.
What to expect
Momentum are conducting a clinical research study investigating a new potential treatment that targets the CNS physiological stress system aiming to normalise the stress response for people with panic disorder. The study aims to demonstrate that the investigational treatment is safer and more tolerable and reduces panic disorder symptoms compared to currently available medicinal treatments.
Please note it is important that study participants remain on any of their current psychiatric medications through the length of the study.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.